Nuvectra (NVTR) Downgraded to Sell at ValuEngine

ValuEngine downgraded shares of Nuvectra (NASDAQ:NVTR) from a hold rating to a sell rating in a research report sent to investors on Friday.

Separately, Piper Jaffray Companies reissued a hold rating and set a $12.00 target price on shares of Nuvectra in a research report on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company. Nuvectra presently has an average rating of Hold and a consensus price target of $12.00.

Nuvectra (NVTR) traded down $0.20 during trading hours on Friday, reaching $8.86. 26,500 shares of the company’s stock traded hands, compared to its average volume of 57,717. Nuvectra has a 12 month low of $4.90 and a 12 month high of $15.00. The company has a current ratio of 2.90, a quick ratio of 2.72 and a debt-to-equity ratio of 0.37.

Nuvectra (NASDAQ:NVTR) last released its earnings results on Wednesday, November 1st. The company reported ($1.09) earnings per share for the quarter, topping the consensus estimate of ($1.16) by $0.07. The company had revenue of $7.60 million for the quarter, compared to the consensus estimate of $8.08 million. Nuvectra had a negative net margin of 204.19% and a negative return on equity of 68.63%. Nuvectra’s revenue was up 100.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.92) EPS. equities research analysts expect that Nuvectra will post -4.77 earnings per share for the current year.

Several hedge funds have recently added to or reduced their stakes in NVTR. Hodges Capital Management Inc. boosted its holdings in shares of Nuvectra by 18.6% in the 2nd quarter. Hodges Capital Management Inc. now owns 227,807 shares of the company’s stock valued at $3,025,000 after acquiring an additional 35,706 shares during the last quarter. Gilder Gagnon Howe & Co. LLC boosted its holdings in shares of Nuvectra by 12.5% in the 2nd quarter. Gilder Gagnon Howe & Co. LLC now owns 953,431 shares of the company’s stock valued at $12,662,000 after acquiring an additional 105,580 shares during the last quarter. Gamco Investors INC. ET AL boosted its holdings in shares of Nuvectra by 4.2% in the 2nd quarter. Gamco Investors INC. ET AL now owns 35,194 shares of the company’s stock valued at $467,000 after acquiring an additional 1,434 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in shares of Nuvectra by 1.3% in the 2nd quarter. Wells Fargo & Company MN now owns 114,492 shares of the company’s stock valued at $1,520,000 after acquiring an additional 1,495 shares during the last quarter. Finally, Northern Trust Corp boosted its holdings in shares of Nuvectra by 1.7% in the 2nd quarter. Northern Trust Corp now owns 169,659 shares of the company’s stock valued at $2,253,000 after acquiring an additional 2,811 shares during the last quarter. 58.89% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: This story was originally reported by Week Herald and is owned by of Week Herald. If you are viewing this story on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this story can be viewed at https://weekherald.com/2017/12/05/nuvectra-nvtr-downgraded-to-sell-at-valuengine.html.

Nuvectra Company Profile

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company’s Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company’s commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Nuvectra Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvectra Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply